• Something wrong with this record ?

Short-term impact of vitamin K2 supplementation on biochemical parameters and lipoprotein fractions

M. Barna, K. Dunovska, J. Cepova, J. Werle, R. Prusa, G. Bjørklud, P. Melichercik, R. Kizek, E. Klapkova

. 2025 ; 46 (3-4) : 152-166. [pub] 20240802

Language English Country Germany

Document type Journal Article

Grant support
00064203 Ministry of Health of the Czech Republic, Motol University Hospital

This study explored the short-term effects of vitamin K2 (VK2) supplementation on biochemical parameters (vitamin D, vitamin E, vitamin A, alkaline phosphatase, calcium, phosphorus (P), magnesium, metallothionein, triglycerides, cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and lipoprotein fractions (albumin, HDL, very low-density lipoprotein (VLDL), LDL, and chylomicrons). A short-term experiment (24 h, six probands) was performed to track changes in VK2 levels after a single-dose intake (360 μg/day). Liquid chromatography-tandem mass spectrometry was used to monitor vitamin K levels (menaquinone-4 (MK-4), menaquinone-7 (MK-7), and vitamin K1 [VK1]) with a limit of detection of 1.9 pg/mL for VK1 and 3.8 pg/mL for the two forms of VK2. Results showed that MK-7 levels significantly increased within 2-6 h post-administration and then gradually declined. MK-4 levels were initially low, showing a slight increase, whereas VK1 levels rose initially and then decreased. Biochemical analyses indicated no significant changes in sodium, chloride, potassium, calcium, magnesium, albumin, or total protein levels. A transient increase in P was observed, peaking at 12 h before returning to baseline. Agarose gel electrophoresis of lipoprotein fractions revealed distinct chylomicron bands and variations in VLDL and HDL mobility, influenced by dietary lipids and VK2 supplementation. These findings suggest effective absorption and metabolism of MK-7 with potential implications for bone metabolism and cardiovascular health.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010141
003      
CZ-PrNML
005      
20250429134554.0
007      
ta
008      
250415s2025 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/elps.202400058 $2 doi
035    __
$a (PubMed)39091191
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Barna, Milos $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia $u First Department of Orthopaedics, First Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia
245    10
$a Short-term impact of vitamin K2 supplementation on biochemical parameters and lipoprotein fractions / $c M. Barna, K. Dunovska, J. Cepova, J. Werle, R. Prusa, G. Bjørklud, P. Melichercik, R. Kizek, E. Klapkova
520    9_
$a This study explored the short-term effects of vitamin K2 (VK2) supplementation on biochemical parameters (vitamin D, vitamin E, vitamin A, alkaline phosphatase, calcium, phosphorus (P), magnesium, metallothionein, triglycerides, cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and lipoprotein fractions (albumin, HDL, very low-density lipoprotein (VLDL), LDL, and chylomicrons). A short-term experiment (24 h, six probands) was performed to track changes in VK2 levels after a single-dose intake (360 μg/day). Liquid chromatography-tandem mass spectrometry was used to monitor vitamin K levels (menaquinone-4 (MK-4), menaquinone-7 (MK-7), and vitamin K1 [VK1]) with a limit of detection of 1.9 pg/mL for VK1 and 3.8 pg/mL for the two forms of VK2. Results showed that MK-7 levels significantly increased within 2-6 h post-administration and then gradually declined. MK-4 levels were initially low, showing a slight increase, whereas VK1 levels rose initially and then decreased. Biochemical analyses indicated no significant changes in sodium, chloride, potassium, calcium, magnesium, albumin, or total protein levels. A transient increase in P was observed, peaking at 12 h before returning to baseline. Agarose gel electrophoresis of lipoprotein fractions revealed distinct chylomicron bands and variations in VLDL and HDL mobility, influenced by dietary lipids and VK2 supplementation. These findings suggest effective absorption and metabolism of MK-7 with potential implications for bone metabolism and cardiovascular health.
650    _2
$a lidé $7 D006801
650    12
$a vitamin K 2 $x analogy a deriváty $x krev $7 D024482
650    12
$a potravní doplňky $x analýza $7 D019587
650    _2
$a mužské pohlaví $7 D008297
650    12
$a lipoproteiny $x krev $7 D008074
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dospělí $7 D000328
650    _2
$a tandemová hmotnostní spektrometrie $x metody $7 D053719
650    _2
$a lidé středního věku $7 D008875
650    _2
$a chromatografie kapalinová $x metody $7 D002853
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dunovska, Katerina $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia
700    1_
$a Cepova, Jana $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia
700    1_
$a Werle, Julia $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia $1 https://orcid.org/0009000112178098
700    1_
$a Prusa, Richard $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia
700    1_
$a Bjørklud, Geir $u Council for Nutritional and Environmental Medicine, Mo i Rana, Norway
700    1_
$a Melichercik, Pavel $u First Department of Orthopaedics, First Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia
700    1_
$a Kizek, Rene $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia
700    1_
$a Klapkova, Eva $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czechia
773    0_
$w MED00001508 $t Electrophoresis $x 1522-2683 $g Roč. 46, č. 3-4 (2025), s. 152-166
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39091191 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134549 $b ABA008
999    __
$a ok $b bmc $g 2311490 $s 1247222
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 46 $c 3-4 $d 152-166 $e 20240802 $i 1522-2683 $m Electrophoresis $n Electrophoresis $x MED00001508
GRA    __
$a 00064203 $p Ministry of Health of the Czech Republic, Motol University Hospital
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...